Loading...

Roly Gosling, PhD, MS, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentEpidemiology & Biostatistics
Address550 16th. Street
San Francisco CA 94158
Phone415-476-5620
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    The malaria elimination initiative is focussed on supporting countries to succeed in elimination of both falciparum and vivax malaria. We have a broad range of activities from desk based research producing advocacy and summary materials to highlight the substantial progress of malaria control and elimination world wide, to field based research exploring active surveillance strategies, efficacy of drug based transmission interventions, costing studies of elimination programs and more qualitative research such as case studies. The program also supports countries by supporting regional networks of countries to eliminate malaria (the Asia Pacific Malaria Elimination Network, APMEN and the Eliminating 8, E8 in southern Africa).

    We do have opportunities to send students to support field research studies.


    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cotter C, Sudathip P, Herdiana H, Cao Y, Liu Y, Luo A, Ranasinghe N, Bennett A, Cao J, Gosling R. Piloting a programme tool to evaluate malaria case investigation and reactive case detection activities: results from 3 settings in the Asia Pacific. Malar J. 2017 Aug 22; 16(1):347. PMID: 28830519.
      View in: PubMed
    2. Smith JL, Auala J, Tambo M, Haindongo E, Katokele S, Uusiku P, Gosling R, Kleinschmidt I, Mumbengegwi D, Sturrock HJW. Spatial clustering of patent and sub-patent malaria infections in northern Namibia: Implications for surveillance and response strategies for elimination. PLoS One. 2017; 12(8):e0180845. PMID: 28820883.
      View in: PubMed
    3. Stone W, Sawa P, Lanke K, Rijpma S, Oriango R, Nyaurah M, Osodo P, Osoti V, Mahamar A, Diawara H, Woestenenk R, Graumans W, van de Vegte-Bolmer M, Bradley J, Chen I, Brown J, Siciliano G, Alano P, Gosling R, Dicko A, Drakeley C, Bousema T. A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance. J Infect Dis. 2017 Aug 15; 216(4):457-467. PMID: 28931236.
      View in: PubMed
    4. Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS, Phru CS, Khan WA, Dysoley L, Qi G, Kheong CC, Shamsudin UK, Chen I, Hwang J, Gosling R, Price RN. Barriers to routine G6PD testing prior to treatment with primaquine. Malar J. 2017 Aug 10; 16(1):329. PMID: 28797255.
      View in: PubMed
    5. Bennett A, Avanceña ALV, Wegbreit J, Cotter C, Roberts K, Gosling R. Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings. Malar J. 2017 Jun 14; 16(1):252. PMID: 28615026.
      View in: PubMed
    6. Björkman A, Cook J, Sturrock H, Msellem M, Ali A, Xu W, Molteni F, Gosling R, Drakeley C, Mårtensson A. Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers. Clin Infect Dis. 2017 05 01; 64(9):1236-1243. PMID: 28431115.
      View in: PubMed
    7. Dlamini N, Hsiang MS, Ntshalintshali N, Pindolia D, Allen R, Nhlabathi N, Novotny J, Kang Dufour MS, Midekisa A, Gosling R, LeMenach A, Cohen J, Dorsey G, Greenhouse B, Kunene S. Low-Quality Housing Is Associated With Increased Risk of Malaria Infection: A National Population-Based Study From the Low Transmission Setting of Swaziland. Open Forum Infect Dis. 2017; 4(2):ofx071. PMID: 28580365.
      View in: PubMed
    8. Smith JL, Auala J, Haindongo E, Uusiku P, Gosling R, Kleinschmidt I, Mumbengegwi D, Sturrock HJ. Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malar J. 2017 Feb 10; 16(1):70. PMID: 28187770.
      View in: PubMed
    9. Liu Y, Sturrock HJW, Yang H, Gosling R, Cao J. The challenge of imported malaria to eliminating countries. Lancet Infect Dis. 2017 Feb; 17(2):141. PMID: 28134113.
      View in: PubMed
    10. Wang D, Cotter C, Sun X, Bennett A, Gosling R, Xiao N. Adapting the local response for malaria elimination through evaluation of the 1-3-7 system performance in the China-Myanmar border region. Malar J. 2017 Jan 31; 16(1):54. PMID: 28137293.
      View in: PubMed
    11. Jacobson JO, Cueto C, Smith JL, Hwang J, Gosling R, Bennett A. Surveillance and response for high-risk populations: what can malaria elimination programmes learn from the experience of HIV? Malar J. 2017 Jan 18; 16(1):33. PMID: 28100237.
      View in: PubMed
    12. Chen I, Gosling R, Drakeley C, Bousema T. Mass Drug Administration for Malaria: A Means to What end? J Infect Dis. 2016 Dec 15; 214(12):1790-1792. PMID: 27923945.
      View in: PubMed
    13. Larson E, Gosling R, Abeyasinghe R. Eliminating malaria: following Sri Lanka's lead. BMJ. 2016 Oct 20; 355:i5517. PMID: 27797788.
      View in: PubMed
    14. Herdiana H, Cotter C, Coutrier FN, Zarlinda I, Zelman BW, Tirta YK, Greenhouse B, Gosling R, Baker P, Whittaker M, Hsiang MS. Malaria risk factor assessment using active and passive surveillance data from Aceh Besar, Indonesia, a low endemic, malaria elimination setting with Plasmodium knowlesi, Plasmodium vivax, and Plasmodium falciparum. Malar J. 2016 Sep 13; 15:468. PMID: 27619000; PMCID: PMC5020529.
    15. Sturrock HJ, Bennett AF, Midekisa A, Gosling R, Gething PW, Greenhouse B, et al. Mapping Malaria Risk in Low Transmission Settings: Challenges and Opportunities. Trends Parasitol. 2016 Aug; 32(8):635-45. PMID: 27238200.
      View in: PubMed
    16. Gosling R, von Seidlein L. The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan. PLoS Med. 2016 Apr; 13(4):e1001994. PMID: 27070151; PMCID: PMC4829262.
    17. Dicko A, Brown JM, Diawara H, Baber I, Mahamar A, Soumare HM, Sanogo K, Koita F, Keita S, Traore SF, Chen I, Poirot E, Hwang J, McCulloch C, Lanke K, Pett H, Niemi M, Nosten F, Bousema T, Gosling R. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial. Lancet Infect Dis. 2016 Jun; 16(6):674-684. PMID: 26906747.
      View in: PubMed
    18. Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, O'Meara W, Price RN, Riley EM. "Asymptomatic" Malaria: A Chronic and Debilitating Infection That Should Be Treated. PLoS Med. 2016 Jan; 13(1):e1001942. PMID: 26783752; PMCID: PMC4718522.
    19. Hsiang MS, Gosling R. Striding Toward Malaria Elimination in China. Am J Trop Med Hyg. 2015 Aug; 93(2):203-4. PMID: 26078325; PMCID: PMC4530732.
    20. Tusting LS, Ippolito MM, Willey BA, Kleinschmidt I, Dorsey G, Gosling R, Lindsay SW. The evidence for improving housing to reduce malaria: a systematic review and meta-analysis. Malar J. 2015 Jun 09; 14:209. PMID: 26055986; PMCID: PMC4460721.
    21. Sturrock HJ, Roberts KW, Wegbreit J, Ohrt C, Gosling R. Tackling imported malaria: an elimination endgame. Am J Trop Med Hyg. 2015 Jul; 93(1):139-44. PMID: 26013369; PMCID: PMC4497886.
    22. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, Shanks GD, Slutsker L, Kachur SP, Wegbreit J, Ippolito MM, Poirot E, Gosling R. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015 Jul; 93(1):125-34. PMID: 26013371; PMCID: PMC4497884.
    23. Gosling J, Case P, Tulloch J, Chandramohan D, Wegbreit J, Newby G, Gueye CS, Koita K, Gosling R. Effective program management: a cornerstone of malaria elimination. Am J Trop Med Hyg. 2015 Jul; 93(1):135-8. PMID: 26013372; PMCID: PMC4497885.
    24. Ohrt C, Roberts KW, Sturrock HJ, Wegbreit J, Lee BY, Gosling R. Information systems to support surveillance for malaria elimination. Am J Trop Med Hyg. 2015 Jul; 93(1):145-52. PMID: 26013378; PMCID: PMC4497887.
    25. Chen I, Poirot E, Newman M, Kandula D, Shah R, Hwang J, Cohen JM, Gosling R, Rooney L. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa. Malar J. 2015 May 15; 14:204. PMID: 25971688; PMCID: PMC4446184.
    26. Snyman K, Mwangwa F, Bigira V, Kapisi J, Clark TD, Osterbauer B, Greenhouse B, Sturrock H, Gosling R, Liu J, Dorsey G. Poor housing construction associated with increased malaria incidence in a cohort of young Ugandan children. Am J Trop Med Hyg. 2015 Jun; 92(6):1207-13. PMID: 25870429; PMCID: PMC4458827.
    27. White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, Eziefula AC, Bousema T, Drakeley C, Chotivanich K, Imwong M, Pukrittayakamee S, Prachumsri J, Chu C, Andolina C, Bancone G, Hien TT, Mayxay M, Taylor WR, von Seidlein L, Price RN, Barnes KI, Djimdé A, Ter Kuile F, Gosling R, Chen I, Dhorda MJ, Stepniewska K, Guérin P, Woodrow CJ, Dondorp AM, Day NP, Nosten FH. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J. 2014 Dec 09; 13:483. PMID: 25486998; PMCID: PMC4295364.
    28. Cook J, Xu W, Msellem M, Vonk M, Bergström B, Gosling R, Al-Mafazy AW, McElroy P, Molteni F, Abass AK, Garimo I, Ramsan M, Ali A, Mårtensson A, Björkman A. Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis. 2015 May 01; 211(9):1476-83. PMID: 25429102.
      View in: PubMed
    29. Chen IT, Gosling R. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose? Expert Rev Clin Pharmacol. 2014 Nov; 7(6):681-6. PMID: 25118908.
      View in: PubMed
    30. Smith Gueye C, Newby G, Hwang J, Phillips AA, Whittaker M, MacArthur JR, Gosling R, Feachem RG. The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion. Malar J. 2014 Jul 27; 13:286. PMID: 25064614; PMCID: PMC4124510.
    31. Cao J, Sturrock HJ, Cotter C, Zhou S, Zhou H, Liu Y, Tang L, Gosling R, Feachem RG, Gao Q. Communicating and monitoring surveillance and response activities for malaria elimination: China's "1-3-7" strategy. PLoS Med. 2014 May; 11(5):e1001642. PMID: 24824170; PMCID: PMC4019513.
    32. Liu JX, Bousema T, Zelman B, Gesase S, Hashim R, Maxwell C, Chandramohan D, Gosling R. Is housing quality associated with malaria incidence among young children and mosquito vector numbers? Evidence from Korogwe, Tanzania. PLoS One. 2014; 9(2):e87358. PMID: 24505285; PMCID: PMC3914816.
    33. Dial NJ, Ceesay SJ, Gosling R, D'Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J. 2014 Feb 04; 13:47. PMID: 24495715; PMCID: PMC3915615.
    34. Liu Y, Hsiang MS, Zhou H, Wang W, Cao Y, Gosling R, Cao J, Gao Q. Malaria in overseas labourers returning to China: an analysis of imported malaria in Jiangsu Province, 2001-2011. Malar J. 2014 Jan 25; 13:29. PMID: 24460982; PMCID: PMC3922785.
    35. Sanders KC, Rundi C, Jelip J, Rashman Y, Smith Gueye C, Gosling R. Eliminating malaria in Malaysia: the role of partnerships between the public and commercial sectors in Sabah. Malar J. 2014 Jan 21; 13:24. PMID: 24443824; PMCID: PMC3917703.
    36. Gosling R, Hsiang MS. Malaria and severe anemia: thinking beyond Plasmodium falciparum. PLoS Med. 2013 Dec; 10(12):e1001576. PMID: 24358032; PMCID: PMC3866086.
    37. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, Cao J, Kachur SP, Feachem RG, Gosling R, Gao Q. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China. Malar J. 2013 Nov 01; 12:383. PMID: 24175930; PMCID: PMC3842644.
    38. Smith Gueye C, Sanders KC, Galappaththy GN, Rundi C, Tobgay T, Sovannaroth S, Gao Q, Surya A, Thakur GD, Baquilod M, Lee WJ, Bobogare A, Deniyage SL, Satimai W, Taleo G, Hung NM, Cotter C, Hsiang MS, Vestergaard LS, Gosling R. Active case detection for malaria elimination: a survey among Asia Pacific countries. Malar J. 2013 Oct 09; 12:358. PMID: 24103345; PMCID: PMC3852840.
    39. Mosha JF, Sturrock HJ, Greenhouse B, Greenwood B, Sutherland CJ, Gadalla N, Atwal S, Drakeley C, Kibiki G, Bousema T, Chandramohan D, Gosling R. Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J. 2013 Jul 01; 12:221. PMID: 23815811; PMCID: PMC3701503.
    40. Liu J, Modrek S, Gosling R, Feachem RG. Malaria eradication: is it possible? Is it worth it? Should we do it? Lancet Glob Health. 2013 Jul; 1(1):e2-3. PMID: 25103582.
      View in: PubMed
    41. Smith DL, Cohen JM, Chiyaka C, Johnston G, Gething PW, Gosling R, Buckee CO, Laxminarayan R, Hay SI, Tatem AJ. A sticky situation: the unexpected stability of malaria elimination. Philos Trans R Soc Lond B Biol Sci. 2013 Aug 05; 368(1623):20120145. PMID: 23798693; PMCID: PMC3720043.
    42. Sturrock HJ, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, Gosling R. Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med. 2013; 10(6):e1001467. PMID: 23853551; PMCID: PMC3708701.
    43. Sturrock HJ, Novotny JM, Kunene S, Dlamini S, Zulu Z, Cohen JM, Hsiang MS, Greenhouse B, Gosling R. Reactive case detection for malaria elimination: real-life experience from an ongoing program in Swaziland. PLoS One. 2013; 8(5):e63830. PMID: 23700437; PMCID: PMC3658965.
    44. Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling R, Feachem RG. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013 Sep 07; 382(9895):900-11. PMID: 23594387.
      View in: PubMed
    45. Bauch JA, Gu JJ, Msellem M, Mårtensson A, Ali AS, Gosling R, Baltzell KA. Perception of malaria risk in a setting of reduced malaria transmission: a qualitative study in Zanzibar. Malar J. 2013 Feb 22; 12:75. PMID: 23433302; PMCID: PMC3584900.
    46. Chiyaka C, Tatem AJ, Cohen JM, Gething PW, Johnston G, Gosling R, Laxminarayan R, Hay SI, Smith DL. Infectious disease. The stability of malaria elimination. Science. 2013 Feb 22; 339(6122):909-10. PMID: 23430640.
      View in: PubMed
    47. Eziefula AC, Gosling R, Hwang J, Hsiang MS, Bousema T, von Seidlein L, Drakeley C. Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J. 2012 Oct 30; 11:360. PMID: 23130957; PMCID: PMC3502539.
    48. Gosling R, Whittaker M, Gueye CS, Fullman N, Baquilod M, Kusriastuti R, Feachem RG. Malaria elimination gaining ground in the Asia Pacific. Malar J. 2012 Oct 18; 11:346. PMID: 23078536; PMCID: PMC3504559.
    49. Gueye CS, Teng A, Kinyua K, Wafula F, Gosling R, McCoy D. Parasites and vectors carry no passport: how to fund cross-border and regional efforts to achieve malaria elimination. Malar J. 2012 Oct 11; 11:344. PMID: 23057734; PMCID: PMC3506506.
    50. Stone W, Bousema T, Jones S, Gesase S, Hashim R, Gosling R, Carneiro I, Chandramohan D, Theander T, Ronca R, Modiano D, Arcà B, Drakeley C. IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk. PLoS One. 2012; 7(6):e40170. PMID: 22768250; PMCID: PMC3387013.
    51. Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, Ghani A, Drakeley C, Gosling R. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med. 2012 Jan; 9(1):e1001165. PMID: 22303287; PMCID: PMC3269430.
    52. Yangzom T, Gueye CS, Namgay R, Galappaththy GN, Thimasarn K, Gosling R, Murugasampillay S, Dev V. Malaria control in Bhutan: case study of a country embarking on elimination. Malar J. 2012 Jan 09; 11:9. PMID: 22230355; PMCID: PMC3278342.
    53. Kunene S, Phillips AA, Gosling R, Kandula D, Novotny JM. A national policy for malaria elimination in Swaziland: a first for sub-Saharan Africa. Malar J. 2011 Oct 21; 10:313. PMID: 22018266; PMCID: PMC3219738.
    54. Gosling R, Okell L, Mosha J, Chandramohan D. The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect. 2011 Nov; 17(11):1617-23. PMID: 21951597.
      View in: PubMed
    55. Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bijllaardt W, Mwanziva C, Semvua S, Masokoto A, Mosha F, Teelen K, Hermsen R, Okell L, Gosling R, Sauerwein R, Bousema T. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J. 2011 Aug 24; 10:247. PMID: 21864343; PMCID: PMC3169516.
    56. Bousema T, Kreuels B, Gosling R. Adjusting for heterogeneity of malaria transmission in longitudinal studies. J Infect Dis. 2011 Jul 01; 204(1):1-3. PMID: 21628650; PMCID: PMC3307167.
    57. Cairns M, Ghani A, Okell L, Gosling R, Carneiro I, Anto F, Asoala V, Owusu-Agyei S, Greenwood B, Chandramohan D, Milligan P. Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children. PLoS One. 2011 Apr 20; 6(4):e18947. PMID: 21533088; PMCID: PMC3080380.
    58. Griffin JT, Cairns M, Ghani AC, Roper C, Schellenberg D, Carneiro I, Newman RD, Grobusch MP, Greenwood B, Chandramohan D, Gosling R. Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One. 2010 Sep 07; 5(9):e12618. PMID: 20838642; PMCID: PMC2935388.
    59. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, Biao P, Masika P, Matovu F, Otieno P, Gosling R, Hamel M, Odhiambo FO, Grobusch MP, Kremsner PG, Chandramohan D, Aponte JJ, Egan A, Schellenberg D, Macete E, Slutsker L, Newman RD, Alonso P, Menéndez C, Tanner M. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS One. 2010 Jun 15; 5(6):e10313. PMID: 20559558; PMCID: PMC2886103.
    60. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, Otieno S, Carneiro I, Cox J, Msuya E, Kleinschmidt I, Maxwell C, Greenwood B, Riley E, Sauerwein R, Chandramohan D, Gosling R. Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis. 2010 Jun 01; 201(11):1764-74. PMID: 20415536.
      View in: PubMed
    61. Gosling R, Cairns ME, Chico RM, Chandramohan D. Intermittent preventive treatment against malaria: an update. Expert Rev Anti Infect Ther. 2010 May; 8(5):589-606. PMID: 20455687.
      View in: PubMed
    62. Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, Hashim R, Kaur H, Lemnge M, Mosha FW, Greenwood B, Chandramohan D. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS One. 2010 Mar 01; 5(3):e9467. PMID: 20209126; PMCID: PMC2830887.
    63. Mosha JF, Conteh L, Tediosi F, Gesase S, Bruce J, Chandramohan D, Gosling R. Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One. 2010 Jan 14; 5(1):e8707. PMID: 20090933; PMCID: PMC2806838.
    64. Yip K, Gosling R, Jones V, Hosein IK. An unusual case of meningococcal meningitis complicated with subdural empyema in a 3 month old infant: a case report. Cases J. 2009 Sep 17; 2:6335. PMID: 20181146; PMCID: PMC2827145.
    65. Gosling R, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Oct 31; 374(9700):1521-32. PMID: 19765815.
      View in: PubMed
    66. Cairns M, Gosling R, Gesase S, Mosha J, Greenwood B, Chandramohan D. Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. Trans R Soc Trop Med Hyg. 2009 Dec; 103(12):1199-201. PMID: 19740503; PMCID: PMC3787296.
    67. Gysels M, Pell C, Mathanga DP, Adongo P, Odhiambo F, Gosling R, Akweongo P, Mwangi R, Okello G, Mangesho P, Slutsker L, Kremsner PG, Grobusch MP, Hamel MJ, Newman RD, Pool R. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J. 2009 Aug 10; 8:191. PMID: 19664250; PMCID: PMC2734860.
    68. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009 Jun 29; 4(6):e6083. PMID: 19562032; PMCID: PMC2698122.
    69. Gosling R, Carneiro I, Chandramohan D. Intermittent preventive treatment of malaria in infants: how does it work and where will it work? Trop Med Int Health. 2009 Sep; 14(9):1003-10. PMID: 19558374.
      View in: PubMed
    70. Gosling R, Chandramohan D. RTS,S/AS01E vaccine against malaria. N Engl J Med. 2009 Mar 19; 360(12):1253; author reply 1253-4. PMID: 19297579.
      View in: PubMed
    71. Gesase S, Gosling R, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One. 2009; 4(2):e4569. PMID: 19238219; PMCID: PMC2644264.
    72. Cairns M, Gosling R, Chandramohan D. Placental malaria increases malaria risk in the first 30 months of life: not causal. Clin Infect Dis. 2009 Feb 15; 48(4):497-8; author reply 498-9. PMID: 19586381.
      View in: PubMed
    73. Ghani AC, Sutherland CJ, Riley EM, Drakeley CJ, Griffin JT, Gosling R, Filipe JA. Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends. PLoS One. 2009; 4(2):e4383. PMID: 19198649; PMCID: PMC2634959.
    74. Mwanziva C, Shekalaghe S, Ndaro A, Mengerink B, Megiroo S, Mosha F, Sauerwein R, Drakeley C, Gosling R, Bousema T. Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J. 2008 Nov 05; 7:232. PMID: 18986520; PMCID: PMC2588630.
    75. Gosling R, Chandramohan D. Tackling malaria today: Beware resurgence of malaria where incidence has fallen. BMJ. 2008 Sep 10; 337:a1592. PMID: 18784170.
      View in: PubMed
    76. Gosling R, Drakeley CJ, Mwita A, Chandramohan D. Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Malar J. 2008 Jul 16; 7:132. PMID: 18631377; PMCID: PMC2488354.
    77. Gosling R. Asymptomatic malaria associated with protection: not causal. Clin Infect Dis. 2008 Jul 01; 47(1):147; author reply 147-8. PMID: 18522513.
      View in: PubMed
    78. Cairns M, Carneiro I, Milligan P, Owusu-Agyei S, Awine T, Gosling R, Greenwood B, Chandramohan D. Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. PLoS One. 2008 May 21; 3(5):e2227. PMID: 18493597; PMCID: PMC2375060.
    79. Gosling R, Ghani AC, Deen JL, von Seidlein L, Greenwood BM, Chandramohan D. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? Malar J. 2008 Apr 03; 7:54. PMID: 18387180; PMCID: PMC2323384.
    80. Gosling R, Drakeley CJ, Chandramohan D. Effective malaria control: better burden estimates needed. Lancet. 2008 Mar 01; 371(9614):724. PMID: 18313500.
      View in: PubMed
    81. Whitty C, Gosling R. Implications of attempts to eliminate malaria for front-line clinicians. Trop Doct. 2008 Jan; 38(1):1-2. PMID: 18302847.
      View in: PubMed
    82. Grobusch MP, Egan A, Gosling R, Newman RD. Intermittent preventive therapy for malaria: progress and future directions. Curr Opin Infect Dis. 2007 Dec; 20(6):613-20. PMID: 17975412.
      View in: PubMed
    83. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One. 2007 Oct 10; 2(10):e1023. PMID: 17925871; PMCID: PMC1995753.
    84. Masika PM, Semarundu WJ, Urassa R, Mosha J, Chandramohan D, Gosling R. Over-diagnosis of malaria is not a lost cause. Malar J. 2006 Dec 13; 5:120. PMID: 17166271; PMCID: PMC1712345.
    85. Gosling R, Schellenberg DM, Chandramohan D. Single-dose sulfadoxine-pyrimethamine in intermittent preventive treatment of malaria. J Infect Dis. 2006 Jun 01; 193(11):1609-10; author reply 1610-1. PMID: 16652293.
      View in: PubMed
    86. Uriyo J, Gosling R, Maddox V, Sam NE, Schimana W, Gillespie SH, McHugh TD. Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania. Ann Trop Med Parasitol. 2006 Apr; 100(3):245-9. PMID: 16630382.
      View in: PubMed
    87. Gillespie SH, Gosling R, Uiso L, Sam NE, Kanduma EG, McHugh TD. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. J Antimicrob Chemother. 2005 Dec; 56(6):1169-71. PMID: 16223939.
      View in: PubMed
    88. Urassa P, Gosling R, Pool R, Reyburn H. Attitudes to voluntary counselling and testing prior to the offer of Nevirapine to prevent vertical transmission of HIV in northern Tanzania. AIDS Care. 2005 Oct; 17(7):842-52. PMID: 16120501.
      View in: PubMed
    89. Drakeley C, Gosling R, Reyburn H. Malaria diagnosis and treatment: one size does not fit all. PLoS Med. 2005 Jun; 2(6):e156; author reply e165. PMID: 15971939; PMCID: PMC1160571.
    90. McHugh TD, Batt SL, Shorten RJ, Gosling R, Uiso L, Gillespie SH. Mycobacterium tuberculosis lineage: a naming of the parts. Tuberculosis (Edinb). 2005 May; 85(3):127-36. PMID: 15850751.
      View in: PubMed
    91. McHugh TD, Pope CF, Ling CL, Patel S, Billington OJ, Gosling R, Lipman MC, Gillespie SH. Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples. J Med Microbiol. 2004 Dec; 53(Pt 12):1215-9. PMID: 15585500.
      View in: PubMed
    92. Bigley VH, Duarte RF, Gosling R, Kibbler CC, Seaton S, Potter M. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant. 2004 Nov; 34(9):815-7. PMID: 15361915.
      View in: PubMed
    93. Gosling R, Uiso LO, Sam NE, Bongard E, Kanduma EG, Nyindo M, Morris RW, Gillespie SH. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med. 2003 Dec 01; 168(11):1342-5. PMID: 12917230.
      View in: PubMed
    94. Gosling R, Heifets L, Gillespie SH. A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs. J Antimicrob Chemother. 2003 Sep; 52(3):473-6. PMID: 12888596.
      View in: PubMed
    95. Gosling R, Mbatia R, Savage A, Mulligan JA, Reyburn H. Prevalence of hospital-acquired infections in a tertiary referral hospital in northern Tanzania. Ann Trop Med Parasitol. 2003 Jan; 97(1):69-73. PMID: 12662424.
      View in: PubMed
    96. Gosling R, Walraven G, Manneh F, Bailey R, Lewis SM. Training health workers to assess anaemia with the WHO haemoglobin colour scale. Trop Med Int Health. 2000 Mar; 5(3):214-21. PMID: 10747285.
      View in: PubMed
    97. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett G, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000 Jan 29; 355(9201):352-7. PMID: 10665554.
      View in: PubMed
    Roly's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP